Galbanic acid potentiates TRAIL induced apoptosis in resistant non-small cell lung cancer cells via inhibition of MDR1 and activation of caspases and DR5

Baumert, 2009, Recent advances in the development of P-gp inhibitors, Anticancer Agents Med. Chem., 9, 415, 10.2174/1871520610909040415 Chen, 2016, Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner, Sci. Rep., 6, 35468, 10.1038/srep35468 Chiang, 2018, Herbal medicines showing Synergistic effects with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) against A549 TRAIL-resistant lung cancer cells: a screening study, Pharmacogn. Mag., 14, 145, 10.4103/pm.pm_270_17 DeSantis, 2014, Cancer treatment and survivorship statistics, CA Cancer J Clin, 64, 252, 10.3322/caac.21235 Eskandani, 2014, Galbanic acid inhibits HIF-1alpha expression via EGFR/HIF-1alpha pathway in cancer cells, Fitoterapia, 101, 1, 10.1016/j.fitote.2014.12.003 Eskandani, 2015, Galbanic acid inhibits HIF-1alpha expression via EGFR/HIF-1alpha pathway in cancer cells, Fitoterapia, 101, 1, 10.1016/j.fitote.2014.12.003 Hanafi-Bojd, 2011, Farnesiferol A from Ferula persica and galbanic acid from Ferula szowitsiana inhibit P-glycoprotein-mediated rhodamine efflux in breast cancer cell lines, Planta Med., 77, 1590, 10.1055/s-0030-1270987 Horak, 2005, Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer, Mol. Cancer Res., 3, 335, 10.1158/1541-7786.MCR-04-0136 Jost, 2009, XIAP discriminates between type I and type II FAS-induced apoptosis, Nature, 460, 1035, 10.1038/nature08229 Kim, 2011, Galbanic acid isolated from Ferula assafoetida exerts in vivo anti-tumor activity in association with anti-angiogenesis and anti-proliferation, Pharm. Res., 28, 597, 10.1007/s11095-010-0311-7 Li, 2014, Compounds from Chinese herbal medicines as reversal agents for P-glycoprotein-mediated multidrug resistance in tumours, Clin. Transl. Oncol., 16, 593, 10.1007/s12094-014-1169-7 Maksimovic-Ivanic, 2012, Resistance to TRAIL and how to surmount it, Immunol. Res., 52, 157, 10.1007/s12026-012-8284-8 Martirosov, 1986, [Changes in thrombocyte aggregation as affected by the sodium salt of galbanic acid in an experiment], Farmakol. i Toksikol., 49, 49 Nazim, 2017, Glipizide sensitizes lung cancer cells to TRAIL-induced apoptosis via Akt/mTOR/autophagy pathways, Oncotarget, 8, 100021, 10.18632/oncotarget.21754 Nestal de Moraes, 2015, FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance, Cell Signal., 27, 2496, 10.1016/j.cellsig.2015.09.013 Oh, 2015, Apoptotic Effect of Galbanic Acid via Activation of Caspases and Inhibition of Mcl-1 in H460 Non-Small Lung Carcinoma Cells, Phytother. Res.: PTR, 29, 844, 10.1002/ptr.5320 Pitti, 1996, Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family, J. Biol. Chem., 271, 12687, 10.1074/jbc.271.22.12687 Rasheduzzaman, 2018, Resveratrol sensitizes lung cancer cell to TRAIL by p53 independent and suppression of Akt/NF-kappaB signaling, Life Sci., 10.1016/j.lfs.2018.07.035 Shahverdi, 2007, Galbanic acid from Ferula szowitsiana enhanced the antibacterial activity of penicillin G and cephalexin against Staphylococcus aureus, Biol. Pharm. Bull., 30, 1805, 10.1248/bpb.30.1805 Shishodia, 2018, Tetrandrine (TET) induces death receptors Apo Trail R1 (DR4) and Apo Trail R2 (DR5) and sensitizes prostate cancer cells to TRAIL-induced apoptosis, Mol. Cancer Ther., 17, 1217, 10.1158/1535-7163.MCT-17-1157 Su, 2015, Reduced SLC27A2 induces cisplatin resistance in lung cancer stem cells by negatively regulating Bmi1-ABCG2 signaling, Mol. Carcinog. Syrov, 1990, [The effect of galbanic acid on the course of experimental hepatitis], Farmakol. i Toksikol., 53, 41 Thomas, 2015, Refining the treatment of NSCLC according to histological and molecular subtypes, Nat. Rev. Clin. Oncol., 12, 511, 10.1038/nrclinonc.2015.90 Trivedi, 2015, Trailing TRAIL resistance: novel targets for TRAIL sensitization in cancer cells, Front. Oncol., 5, 69, 10.3389/fonc.2015.00069 Twentyman, 1994, A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes, Eur. J. Cancer, 30A, 1360, 10.1016/0959-8049(94)90187-2 Wang, 2014, The molecular mechanisms of TRAIL resistance in cancer cells: help in designing new drugs, Curr. Pharm. Des., 20, 6714, 10.2174/1381612820666140929100735 Wang, 2003, TRAIL and apoptosis induction by TNF-family death receptors, Oncogene, 22, 8628, 10.1038/sj.onc.1207232 Wang, 2018, Gambogic acid sensitizes breast cancer cells to TRAIL-induced apoptosis by promoting the crosstalk of extrinsic and intrinsic apoptotic signalings, Food Chem. Toxicol.: Int. J. Publ. Br. Ind. Biol. Res. Assoc. Xu, 2018, Irigenin sensitizes TRAIL-induced apoptosis via enhancing pro-apoptotic molecules in gastric cancer cells, Biochem. Biophys. Res. Commun., 496, 998, 10.1016/j.bbrc.2018.01.003 Yin, 2013, Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor, Adv. Drug Deliv. Rev., 65, 1699, 10.1016/j.addr.2013.04.011 You, 2018, Trichosanthin enhances sensitivity of non-small cell lung cancer (NSCLC) TRAIL-resistance cells, Int. J. Biol. Sci., 14, 217, 10.7150/ijbs.22811 Zhang, 2011, Galbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells, Int. J. Cancer, 130, 200, 10.1002/ijc.25993 Zhang, 2012, Galbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells, Int. J. Cancer, 130, 200, 10.1002/ijc.25993 Zhang, 2015, 244-MPT over comes gefitinib resistance in non-small cell lung cancer cells, Oncotarget